Related Experiment Videos
[Intraprostatic embolization of cholesterol crystals].
J Planas Morin1, F Aguiló Lucía, F J Suárez Novo
1Servicio de Urología, Hospital Universitario de Bellvitge, Barcelona.
Actas Urologicas Espanolas
|March 25, 2005
Summary
Cholesterol embolism syndrome (CES) is a rare, high-mortality disease. Intraprostatic cholesterol crystals after prostate biopsy may indicate CES in patients with atherosclerosis risk factors.
Area of Science:
- Urology
- Nephrology
- Cardiovascular Medicine
Background:
- Cholesterol embolism syndrome (CES) is a rare but serious condition.
- It is associated with significant morbidity and mortality.
- CES can manifest with diverse clinical symptoms, often mimicking other diseases.
Observation:
- A case is presented where intraprostatic cholesterol crystal embolization was identified.
- This finding occurred following a transrectal prostate biopsy.
- The patient had multiple risk factors for atherosclerosis.
Findings:
- The presence of cholesterol crystals within the prostate post-biopsy suggests a potential diagnostic clue for CES.
- This specific finding can be linked to systemic cholesterol emboli.
Implications:
- Urologists should consider CES in patients presenting with risk factors for atherosclerosis and evidence of cholesterol emboli post-biopsy.
- Early recognition of CES is crucial for timely management and potentially improving patient outcomes.
- This highlights the importance of histopathological examination in diagnosing systemic conditions.